248 related articles for article (PubMed ID: 25639486)
41. Forkhead Box M1 Is Essential for Nuclear Localization of Glioma-associated Oncogene Homolog 1 in Glioblastoma Multiforme Cells by Promoting Importin-7 Expression.
Xue J; Zhou A; Tan C; Wu Y; Lee HT; Li W; Xie K; Huang S
J Biol Chem; 2015 Jul; 290(30):18662-70. PubMed ID: 26085085
[TBL] [Abstract][Full Text] [Related]
42. miR-577 inhibits glioblastoma tumor growth via the Wnt signaling pathway.
Zhang W; Shen C; Li C; Yang G; Liu H; Chen X; Zhu D; Zou H; Zhen Y; Zhang D; Zhao S
Mol Carcinog; 2016 May; 55(5):575-85. PubMed ID: 25764520
[TBL] [Abstract][Full Text] [Related]
43. Somatic POLE mutations cause an ultramutated giant cell high-grade glioma subtype with better prognosis.
Erson-Omay EZ; Çağlayan AO; Schultz N; Weinhold N; Omay SB; Özduman K; Köksal Y; Li J; Serin Harmancı A; Clark V; Carrión-Grant G; Baranoski J; Çağlar C; Barak T; Coşkun S; Baran B; Köse D; Sun J; Bakırcıoğlu M; Moliterno Günel J; Pamir MN; Mishra-Gorur K; Bilguvar K; Yasuno K; Vortmeyer A; Huttner AJ; Sander C; Günel M
Neuro Oncol; 2015 Oct; 17(10):1356-64. PubMed ID: 25740784
[TBL] [Abstract][Full Text] [Related]
44. CNS cancer: periostin-a new potential target for the treatment of glioblastoma.
Errico A
Nat Rev Clin Oncol; 2015 Mar; 12(3):128. PubMed ID: 25645602
[No Abstract] [Full Text] [Related]
45. TRIM proteins legitimately enter the MAGEic RING.
Zanchetta ME; Meroni G
Cell Cycle; 2015; 14(8):1134-5. PubMed ID: 25695405
[No Abstract] [Full Text] [Related]
46. A pooled multisite analysis of the effects of atopic medical conditions in glioma risk in different ethnic groups.
Krishnamachari B; Il'yasova D; Scheurer ME; Bondy M; Zhou R; Wrensch M; Davis F
Ann Epidemiol; 2015 Apr; 25(4):270-4. PubMed ID: 25691445
[TBL] [Abstract][Full Text] [Related]
47. Variation over time and interdependence between disease progression and death among patients with glioblastoma on RTOG 0525.
Wang M; Dignam JJ; Won M; Curran W; Mehta M; Gilbert MR
Neuro Oncol; 2015 Jul; 17(7):999-1006. PubMed ID: 25688120
[TBL] [Abstract][Full Text] [Related]
48. MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial.
Weller M; Tabatabai G; Kästner B; Felsberg J; Steinbach JP; Wick A; Schnell O; Hau P; Herrlinger U; Sabel MC; Wirsching HG; Ketter R; Bähr O; Platten M; Tonn JC; Schlegel U; Marosi C; Goldbrunner R; Stupp R; Homicsko K; Pichler J; Nikkhah G; Meixensberger J; Vajkoczy P; Kollias S; Hüsing J; Reifenberger G; Wick W;
Clin Cancer Res; 2015 May; 21(9):2057-64. PubMed ID: 25655102
[TBL] [Abstract][Full Text] [Related]
49. Setting the stage: local delivery of cytoreductive agents for the treatment of glioblastoma.
Kalkanis SN
Neuro Oncol; 2015 Mar; 17 Suppl 2(Suppl 2):ii1-ii2. PubMed ID: 25746088
[No Abstract] [Full Text] [Related]
50. FoxM1 Drives a Feed-Forward STAT3-Activation Signaling Loop That Promotes the Self-Renewal and Tumorigenicity of Glioblastoma Stem-like Cells.
Gong AH; Wei P; Zhang S; Yao J; Yuan Y; Zhou AD; Lang FF; Heimberger AB; Rao G; Huang S
Cancer Res; 2015 Jun; 75(11):2337-48. PubMed ID: 25832656
[TBL] [Abstract][Full Text] [Related]
51. Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment.
van Thuijl HF; Mazor T; Johnson BE; Fouse SD; Aihara K; Hong C; Malmström A; Hallbeck M; Heimans JJ; Kloezeman JJ; Stenmark-Askmalm M; Lamfers ML; Saito N; Aburatani H; Mukasa A; Berger MS; Söderkvist P; Taylor BS; Molinaro AM; Wesseling P; Reijneveld JC; Chang SM; Ylstra B; Costello JF
Acta Neuropathol; 2015 Apr; 129(4):597-607. PubMed ID: 25724300
[TBL] [Abstract][Full Text] [Related]
52. Linc00210 drives Wnt/β-catenin signaling activation and liver tumor progression through CTNNBIP1-dependent manner.
Fu X; Zhu X; Qin F; Zhang Y; Lin J; Ding Y; Yang Z; Shang Y; Wang L; Zhang Q; Gao Q
Mol Cancer; 2018 Mar; 17(1):73. PubMed ID: 29540185
[TBL] [Abstract][Full Text] [Related]
53. Nuclear GSK3β promotes tumorigenesis by phosphorylating KDM1A and inducing its deubiquitylation by USP22.
Zhou A; Lin K; Zhang S; Chen Y; Zhang N; Xue J; Wang Z; Aldape KD; Xie K; Woodgett JR; Huang S
Nat Cell Biol; 2016 Sep; 18(9):954-966. PubMed ID: 27501329
[TBL] [Abstract][Full Text] [Related]
54. Corrigendum: Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation.
Yang W; Xia Y; Ji H; Zheng Y; Liang J; Huang W; Gao X; Aldape K; Lu Z
Nature; 2017 Sep; 550(7674):142. PubMed ID: 28953868
[TBL] [Abstract][Full Text] [Related]
55. Erythropoietin Stimulates Tumor Growth via EphB4.
Pradeep S; Huang J; Mora EM; Nick AM; Cho MS; Wu SY; Noh K; Pecot CV; Rupaimoole R; Stein MA; Brock S; Wen Y; Xiong C; Gharpure K; Hansen JM; Nagaraja AS; Previs RA; Vivas-Mejia P; Han HD; Hu W; Mangala LS; Zand B; Stagg LJ; Ladbury JE; Ozpolat B; Alpay SN; Nishimura M; Stone RL; Matsuo K; Armaiz-Peña GN; Dalton HJ; Danes C; Goodman B; Rodriguez-Aguayo C; Kruger C; Schneider A; Haghpeykar S; Jaladurgam P; Hung MC; Coleman RL; Liu J; Li C; Urbauer D; Lopez-Berestein G; Jackson DB; Sood AK
Cancer Cell; 2015 Nov; 28(5):610-622. PubMed ID: 26481148
[TBL] [Abstract][Full Text] [Related]
56. ATF5 Connects the Pericentriolar Materials to the Proximal End of the Mother Centriole.
Madarampalli B; Yuan Y; Liu D; Lengel K; Xu Y; Li G; Yang J; Liu X; Lu Z; Liu DX
Cell; 2015 Jul; 162(3):580-92. PubMed ID: 26213385
[TBL] [Abstract][Full Text] [Related]
57. Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells.
Basu-Roy U; Bayin NS; Rattanakorn K; Han E; Placantonakis DG; Mansukhani A; Basilico C
Nat Commun; 2015 Apr; 6():6411. PubMed ID: 25832504
[TBL] [Abstract][Full Text] [Related]
58. Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study.
Nabors LB; Fink KL; Mikkelsen T; Grujicic D; Tarnawski R; Nam DH; Mazurkiewicz M; Salacz M; Ashby L; Zagonel V; Depenni R; Perry JR; Hicking C; Picard M; Hegi ME; Lhermitte B; Reardon DA
Neuro Oncol; 2015 May; 17(5):708-17. PubMed ID: 25762461
[TBL] [Abstract][Full Text] [Related]
59. Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma.
Ramkissoon SH; Bi WL; Schumacher SE; Ramkissoon LA; Haidar S; Knoff D; Dubuc A; Brown L; Burns M; Cryan JB; Abedalthagafi M; Kang YJ; Schultz N; Reardon DA; Lee EQ; Rinne ML; Norden AD; Nayak L; Ruland S; Doherty LM; LaFrankie DC; Horvath M; Aizer AA; Russo A; Arvold ND; Claus EB; Al-Mefty O; Johnson MD; Golby AJ; Dunn IF; Chiocca EA; Trippa L; Santagata S; Folkerth RD; Kantoff P; Rollins BJ; Lindeman NI; Wen PY; Ligon AH; Beroukhim R; Alexander BM; Ligon KL
Neuro Oncol; 2015 Oct; 17(10):1344-55. PubMed ID: 25754088
[TBL] [Abstract][Full Text] [Related]
60. A practical review of prognostic correlations of molecular biomarkers in glioblastoma.
Karsy M; Neil JA; Guan J; Mahan MA; Colman H; Jensen RL
Neurosurg Focus; 2015 Mar; 38(3):E4. PubMed ID: 25727226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
